E. ÜÇTEPE Et Al. , "Matrix metalloproteinase 2, 3, 9, 10, 13 gene polymorphisms and risk for polycythemia and essential thrombocytosis patients," American Society of Human Genetics 63rd Annual Meeting , Boston, United States Of America, 2013
ÜÇTEPE, E. Et Al. 2013. Matrix metalloproteinase 2, 3, 9, 10, 13 gene polymorphisms and risk for polycythemia and essential thrombocytosis patients. American Society of Human Genetics 63rd Annual Meeting , (Boston, United States Of America).
ÜÇTEPE, E., MARAL, S., BENDER, O., YAŞAR, T., GÜNDÜZ, E., & GÜNDÜZ, M., (2013). Matrix metalloproteinase 2, 3, 9, 10, 13 gene polymorphisms and risk for polycythemia and essential thrombocytosis patients . American Society of Human Genetics 63rd Annual Meeting, Boston, United States Of America
ÜÇTEPE, EYYÜP Et Al. "Matrix metalloproteinase 2, 3, 9, 10, 13 gene polymorphisms and risk for polycythemia and essential thrombocytosis patients," American Society of Human Genetics 63rd Annual Meeting, Boston, United States Of America, 2013
ÜÇTEPE, EYYÜP Et Al. "Matrix metalloproteinase 2, 3, 9, 10, 13 gene polymorphisms and risk for polycythemia and essential thrombocytosis patients." American Society of Human Genetics 63rd Annual Meeting , Boston, United States Of America, 2013
ÜÇTEPE, E. Et Al. (2013) . "Matrix metalloproteinase 2, 3, 9, 10, 13 gene polymorphisms and risk for polycythemia and essential thrombocytosis patients." American Society of Human Genetics 63rd Annual Meeting , Boston, United States Of America.
@conferencepaper{conferencepaper, author={EYYÜP ÜÇTEPE Et Al. }, title={Matrix metalloproteinase 2, 3, 9, 10, 13 gene polymorphisms and risk for polycythemia and essential thrombocytosis patients}, congress name={American Society of Human Genetics 63rd Annual Meeting}, city={Boston}, country={United States Of America}, year={2013}}